Trial · NCT04516291
Participant flow48
How many started, completed or left each group, period by period.
1 to 20 of 48
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period (24 Weeks) | STARTED | Placebo | 44 | |
| Treatment Period (24 Weeks) | STARTED | Vupanorsen: 80 mg Q4W | 23 | |
| Treatment Period (24 Weeks) | STARTED | Vupanorsen: 60 mg Q2W | 24 | |
| Treatment Period (24 Weeks) | STARTED | Vupanorsen: 120 mg Q4W | 23 | |
| Treatment Period (24 Weeks) | STARTED | Vupanorsen: 80 mg Q2W | 45 | |
| Treatment Period (24 Weeks) | STARTED | Vupanorsen: 160 mg Q4W | 45 | |
| Treatment Period (24 Weeks) | STARTED | Vupanorsen: 120 mg Q2W | 46 | |
| Treatment Period (24 Weeks) | STARTED | Vupanorsen: 160 mg Q2W | 36 | |
| Treatment Period (24 Weeks) | COMPLETED | Placebo | 42 | |
| Treatment Period (24 Weeks) | COMPLETED | Vupanorsen: 80 mg Q4W | 18 | |
| Treatment Period (24 Weeks) | COMPLETED | Vupanorsen: 60 mg Q2W | 20 | |
| Treatment Period (24 Weeks) | COMPLETED | Vupanorsen: 120 mg Q4W | 17 | |
| Treatment Period (24 Weeks) | COMPLETED | Vupanorsen: 80 mg Q2W | 33 | |
| Treatment Period (24 Weeks) | COMPLETED | Vupanorsen: 160 mg Q4W | 37 | |
| Treatment Period (24 Weeks) | COMPLETED | Vupanorsen: 120 mg Q2W | 37 | |
| Treatment Period (24 Weeks) | COMPLETED | Vupanorsen: 160 mg Q2W | 22 | |
| Treatment Period (24 Weeks) | NOT COMPLETED | Placebo | 2 | |
| Treatment Period (24 Weeks) | NOT COMPLETED | Vupanorsen: 80 mg Q4W | 5 | |
| Treatment Period (24 Weeks) | NOT COMPLETED | Vupanorsen: 60 mg Q2W | 4 | |
| Treatment Period (24 Weeks) | NOT COMPLETED | Vupanorsen: 120 mg Q4W | 6 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04516291/flow